Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Issue 10 (22nd May 2017)

• Record Type: Journal Article
• Authors: Kolkhir, P.; Metz, M.; Altrichter, S.; Maurer, M.
• Is Part Of: Allergy. Volume 72:Issue 10(2017:Oct.)
• Page Start: 1440
• Page End: 1460
• Publication Date: 2017-05-22
• Subjects: chronic spontaneous urticaria -- Graves' disease -- Hashimoto's thyroiditis -- prevalence -- autoimmune thyroid disease; Allergy -- Periodicals; 616.97
• DOI: 10.1111/all.13182
• Languages: English
• ISSNs: 0105-4538

Abstract

Abstract: Patients with chronic spontaneous urticaria (CSU) are widely held to often have other autoimmune disorders, including autoimmune thyroid disease. Here, we systematically evaluated the literature on the prevalence of thyroid autoimmunity in CSU and vice versa. There is a strong link between CSU and elevated levels of IgG antithyroid autoantibodies (AAbs), with most of a large number of studies reporting rates of ≥10%. Levels of IgG against thyroid peroxidase (TPO) are more often elevated in CSU than those of other IgG antithyroid AAbs (strong evidence). Levels of IgG antithyroid AAbs are more often elevated in adult patients with CSU than in children (strong evidence). Patients with CSU exhibit significantly higher levels of IgG antithyroid AAbs (strong evidence) and IgE‐anti‐TPO (weak evidence) than controls. Elevated IgG antithyroid AAbs in CSU are linked to the use of glucocorticoids (weak evidence) but not to disease duration or severity/activity, gender, age, or ASST response (inconsistent evidence). Thyroid dysfunction rates are increased in patients with CSU (strong evidence). Hypothyroidism and Hashimoto's thyroiditis are more common than hyperthyroidism and Graves' disease (strong evidence). Thyroid dysfunction is more common in adult patients with CSU than in children (strong evidence) and in female than in male patients with CSU (weak evidence). Urticaria including CSU is more prevalent in patients with thyroid autoimmunity than in controls (weak evidence). CSU can improve in response to treatment with levothyroxine or other thyroid drugs (strong evidence). Pathogenic mechanisms in CSU patients with thyroid autoimmunity may include IgE against autoantigens, immune complexes, and complement.